Trial Profile
Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2019
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics; Proof of concept
- Acronyms VOR-IISR
- 23 Sep 2019 Status changed from recruiting to discontinued.
- 09 May 2018 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
- 09 May 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.